Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. L. Loman

Publicaties

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

Hand eczema-related presenteeism and sickness absence: A cross-sectional population-based study

Health literacy in adult patients with atopic dermatitis: A cross-sectional study

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis

Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews

Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry

Limited Health Literacy and Its Associated Health Outcomes Among Adults With at Least 2 Atopic Diseases

Successful tapering of dupilumab in atopic dermatitis patients with low disease activity: a large pragmatic daily practice study from the BioDay registry

Validity, reliability, responsiveness, and interpretability of the Recap of atopic eczema (RECAP) questionnaire

Lees meer

Pers/media

Handeczeem: welke invloed heeft de leefstijl hierop?